About Remedee Labs
Remedee Labs is a company based in Meylan (France) founded in 2016 by Jacques Husser and David Crouzier. Remedee Labs has raised $27.83 million across 3 funding rounds from investors including Generali, PAR Technology Corp and Bpifrance. Remedee Labs offers products and services including Novi Rem™, Fibro Rem™, and Remedee Bracelet. Remedee Labs operates in a competitive market with competitors including NeuroMetrix, Sky Medical Technology, Electromedical Technologies, Sure Med Compliance and Neurolytic Healthcare, among others.
- Headquarter Meylan, France
- Founders Jacques Husser, David Crouzier
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Remedee Labs
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$27.83 M (USD)
in 3 rounds
-
Latest Funding Round
$12.86 M (USD), Series A
Dec 06, 2022
-
Investors
Generali
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Remedee Labs
Remedee Labs offers a comprehensive portfolio of products and services, including Novi Rem™, Fibro Rem™, and Remedee Bracelet.
Device for relieving arthrose pain through neuromodulation
Solution for managing fibromyalgie symptoms via endorphin stimulation
Bracelet that stimulates endorphins to reduce chronic pain
Funding Insights of Remedee Labs
Remedee Labs has successfully raised a total of $27.83M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $12.86 million completed in December 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Remedee Labs
Remedee Labs has secured backing from 7 investors, including institutional and venture fund investors. Prominent investors backing the company include Generali, PAR Technology Corp and Bpifrance.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments are directed toward hard-tech and full-stack companies by HCVC.
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Venture capital fund focused on series A stage hardware, future work, commerce, and digital media companies
|
Locked | Locked | Locked |
Investor details for Remedee Labs
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Remedee Labs
Investment portfolio details for Remedee Labs
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Remedee Labs
Detailed financials for Remedee Labs
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Remedee Labs Comparisons
Peer comparison for Remedee Labs
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Remedee Labs
Remedee Labs operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as NeuroMetrix, Sky Medical Technology, Electromedical Technologies, Sure Med Compliance and Neurolytic Healthcare, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable technology for pain, nerve disease and sleep disorders
|
|
| Locked | Locked | Locked |
Electro-stimulation devices are manufactured for deep vein thrombosis treatment.
|
|
| Locked | Locked | Locked |
An electrotherapy device that helps reduce and eliminate chronic or acute pain
|
|
| Locked | Locked | Locked |
Provider of a digital health platform for pain management
|
|
| Locked | Locked | Locked |
Smart medical devices for neurological disorder treatment are developed.
|
Detailed competitors of Remedee Labs
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Remedee Labs
Complete news archive for Remedee Labs
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Remedee Labs
Remedee Labs was founded in 2016.
Remedee Labs is headquartered in Meylan, France. It is registered at Meylan, Isere, France.
David Crouzier is the current CEO of Remedee Labs. They have also founded this company.
Remedee Labs is a funded company, having raised a total of $27.83M across 3 funding rounds to date.
Remedee Labs was founded in 2016 in Meylan, France, within the health technology sector. Patented Microelectronic Endorphin Trigger (MEET) technology is utilized to develop therapies for pain management. Ongoing clinical trials address conditions including innocuity, arthrosis, surgical pain, and migraine. Operations focus on advancing non-invasive endorphin-based treatments through research and validation processes.
Remedee Labs's top competitors include Sky Medical Technology, Electromedical Technologies and Sure Med Compliance.
Remedee Labs offers Novi Rem™, Fibro Rem™, and Remedee Bracelet.
Remedee Labs has 7 investors. Key investors include Generali, PAR Technology Corp, Bpifrance, HCVC, and Habert Dassault Finance.